FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224216681> ?p ?o ?g. }

• W4224216681 endingPage "94" @default.
• W4224216681 startingPage "85" @default.
• W4224216681 abstract "Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are two cholinergic enzymes catalyzing the reaction of cleaving acetylcholine into acetate and choline at the neuromuscular junction. Abnormal hyperactivity of AChE and BChE can lead to cholinergic deficiency, which is associated with several neurological disorders including cognitive decline and memory impairments. Preclinical studies support that some cannabinoids including cannabidiol (CBD) and tetrahydrocannabinol (THC) may exert pharmacological effects on the cholinergic system, but it remains unclear whether cannabinoids can inhibit AChE and BChE activities. Herein, we aimed to evaluate the inhibitory effects of a panel of cannabinoids including CBD, Δ8-THC, cannabigerol (CBG), cannabigerolic acid (CBGA), cannabicitran (CBT), cannabidivarin (CBDV), cannabichromene (CBC), and cannabinol (CBN) on AChE and BChE activities.The inhibitory effects of cannabinoids on the activities of AChE and BChE enzymes were evaluated with the Ellman method using acetyl- and butyryl-thiocholines as substrates. The inhibition mechanism of cannabinoids on AChE and BChE was studied with enzyme kinetic assays including the Lineweaver-Burk and Michaelis-Menten analyses. In addition, computational-based molecular docking experiments were performed to explore the interactions between the cannabinoids and the enzyme proteins.Cannabinoids including CBD, Δ8-THC, CBG, CBGA, CBT, CBDV, CBC, and CBN (at 200 µM) inhibited the activities of AChE and BChE by 70.8, 83.7, 92.9, 76.7, 66.0, 79.3, 13.7, and 30.5%, and by 86.8, 80.8, 93.2, 87.1, 77.0, 78.5, 27.9, and 22.0%, respectively. The inhibitory effects of these cannabinoids (with IC50 values ranging from 85.2 to >200 µM for AChE and 107.1 to >200 µM for BChE) were less potent as compared to the positive control galantamine (IC50 1.21 and 6.86 µM for AChE and BChE, respectively). In addition, CBD, as a representative cannabinoid, displayed a competitive type of inhibition on both AChE and BChE. Data from the molecular docking studies suggested that cannabinoids interacted with several amino acid residues on the enzyme proteins, which supported their overall inhibitory effects on AChE and BChE.Cannabinoids showed moderate inhibitory effects on the activities of AChE and BChE enzymes, which may contribute to their modulatory effects on the cholinergic system. Further studies using cell-based and in vivo models are warranted to evaluate whether cannabinoids' neuroprotective effects are associated with their anti-cholinesterase activities." @default.
• W4224216681 created "2022-04-26" @default.
• W4224216681 creator A5022256556 @default.
• W4224216681 creator A5030631170 @default.
• W4224216681 creator A5041080185 @default.
• W4224216681 creator A5068751110 @default.
• W4224216681 date "2022-04-19" @default.
• W4224216681 modified "2023-10-14" @default.
• W4224216681 title "Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities" @default.
• W4224216681 cites W1981945499 @default.
• W4224216681 cites W2013960149 @default.
• W4224216681 cites W2017327362 @default.
• W4224216681 cites W2025205963 @default.
• W4224216681 cites W2054106674 @default.
• W4224216681 cites W2059809207 @default.
• W4224216681 cites W2060177739 @default.
• W4224216681 cites W2074076862 @default.
• W4224216681 cites W2100274941 @default.
• W4224216681 cites W2113097250 @default.
• W4224216681 cites W2142587255 @default.
• W4224216681 cites W2158603760 @default.
• W4224216681 cites W2215598834 @default.
• W4224216681 cites W2261085470 @default.
• W4224216681 cites W2322692561 @default.
• W4224216681 cites W2526271992 @default.
• W4224216681 cites W2790542561 @default.
• W4224216681 cites W2893930979 @default.
• W4224216681 cites W2978711760 @default.
• W4224216681 cites W3009127307 @default.
• W4224216681 cites W3016551749 @default.
• W4224216681 cites W3021258444 @default.
• W4224216681 cites W3025281036 @default.
• W4224216681 cites W3127715262 @default.
• W4224216681 doi "https://doi.org/10.1159/000524086" @default.
• W4224216681 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35702400" @default.
• W4224216681 hasPublicationYear "2022" @default.
• W4224216681 type Work @default.
• W4224216681 citedByCount "9" @default.
• W4224216681 countsByYear W42242166812022 @default.
• W4224216681 countsByYear W42242166812023 @default.
• W4224216681 crossrefType "journal-article" @default.
• W4224216681 hasAuthorship W4224216681A5022256556 @default.
• W4224216681 hasAuthorship W4224216681A5030631170 @default.
• W4224216681 hasAuthorship W4224216681A5041080185 @default.
• W4224216681 hasAuthorship W4224216681A5068751110 @default.
• W4224216681 hasBestOaLocation W42242166811 @default.
• W4224216681 hasConcept C118552586 @default.
• W4224216681 hasConcept C126322002 @default.
• W4224216681 hasConcept C170493617 @default.
• W4224216681 hasConcept C181199279 @default.
• W4224216681 hasConcept C185592680 @default.
• W4224216681 hasConcept C22885893 @default.
• W4224216681 hasConcept C2775910092 @default.
• W4224216681 hasConcept C2776895053 @default.
• W4224216681 hasConcept C2777056318 @default.
• W4224216681 hasConcept C2778816929 @default.
• W4224216681 hasConcept C2779059548 @default.
• W4224216681 hasConcept C2779101902 @default.
• W4224216681 hasConcept C2780871563 @default.
• W4224216681 hasConcept C2781090866 @default.
• W4224216681 hasConcept C31896038 @default.
• W4224216681 hasConcept C55493867 @default.
• W4224216681 hasConcept C71924100 @default.
• W4224216681 hasConcept C98274493 @default.
• W4224216681 hasConceptScore W4224216681C118552586 @default.
• W4224216681 hasConceptScore W4224216681C126322002 @default.
• W4224216681 hasConceptScore W4224216681C170493617 @default.
• W4224216681 hasConceptScore W4224216681C181199279 @default.
• W4224216681 hasConceptScore W4224216681C185592680 @default.
• W4224216681 hasConceptScore W4224216681C22885893 @default.
• W4224216681 hasConceptScore W4224216681C2775910092 @default.
• W4224216681 hasConceptScore W4224216681C2776895053 @default.
• W4224216681 hasConceptScore W4224216681C2777056318 @default.
• W4224216681 hasConceptScore W4224216681C2778816929 @default.
• W4224216681 hasConceptScore W4224216681C2779059548 @default.
• W4224216681 hasConceptScore W4224216681C2779101902 @default.
• W4224216681 hasConceptScore W4224216681C2780871563 @default.
• W4224216681 hasConceptScore W4224216681C2781090866 @default.
• W4224216681 hasConceptScore W4224216681C31896038 @default.
• W4224216681 hasConceptScore W4224216681C55493867 @default.
• W4224216681 hasConceptScore W4224216681C71924100 @default.
• W4224216681 hasConceptScore W4224216681C98274493 @default.
• W4224216681 hasIssue "1" @default.
• W4224216681 hasLocation W42242166811 @default.
• W4224216681 hasLocation W42242166812 @default.
• W4224216681 hasLocation W42242166813 @default.
• W4224216681 hasLocation W42242166814 @default.
• W4224216681 hasOpenAccess W4224216681 @default.
• W4224216681 hasPrimaryLocation W42242166811 @default.
• W4224216681 hasRelatedWork W1562859000 @default.
• W4224216681 hasRelatedWork W180149584 @default.
• W4224216681 hasRelatedWork W1843542419 @default.
• W4224216681 hasRelatedWork W1987170637 @default.
• W4224216681 hasRelatedWork W2060177739 @default.
• W4224216681 hasRelatedWork W2096927450 @default.
• W4224216681 hasRelatedWork W2237008908 @default.
• W4224216681 hasRelatedWork W4224216681 @default.
• W4224216681 hasRelatedWork W4247229566 @default.

• next